Health and Fitness Health and Fitness
Tue, September 18, 2012
[ Tue, Sep 18th 2012 ] - Market Wire
ACT to Present at Terrapinn’s Stem Cells & Regenerative Medicine Congress in Boston
[ Tue, Sep 18th 2012 ] - Market Wire
Yuchun Lee Appointed to the Vertex Board of Directors
[ Tue, Sep 18th 2012 ] - Market Wire
Consumers Starting to Comparison-Shop for Health .. Services and Treatments, According to New Survey
[ Tue, Sep 18th 2012 ] - Market Wire
Catasys’ OnTrak™ Program Cont .. More Than 50% Savings to Its Health Plan Clients
[ Tue, Sep 18th 2012 ] - Market Wire
Synta to Present Interim Results from the GALAXY™ Trial at ESMO 2012
[ Tue, Sep 18th 2012 ] - Market Wire
Navidea Biopharmaceuticals Announces Enrollment o .. ial of NAV4694 as an Aid in Diagnosing Alzheimer&
[ Tue, Sep 18th 2012 ] - Market Wire
MolecularMD and ARIAD Announce Voluntary Withdraw .. Premarket Approval Application For BCR-ABL T315I
[ Tue, Sep 18th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Presentation .. nd Webcast at UBS Global Life Sciences Conference
[ Tue, Sep 18th 2012 ] - Market Wire
AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
[ Tue, Sep 18th 2012 ] - Market Wire
New U.S. Composition of Matter Patent for Aradigm .. ; and Lipoquin™ Provides Protection
[ Tue, Sep 18th 2012 ] - Market Wire
Illumina Introduces TruSeq®; Stranded mRNA .. Total RNA Sequencing Sample Preparation Solutions
[ Tue, Sep 18th 2012 ] - Market Wire
Greystone Logistics Achieves Milestone
[ Tue, Sep 18th 2012 ] - Market Wire
CML HealthCare Inc. Announces Strategic Plan and Senior Management Enhancements
[ Tue, Sep 18th 2012 ] - Market Wire
CML HealthCare Inc. and MaRS Innovation Enter into Strategic Partnership
[ Tue, Sep 18th 2012 ] - Market Wire
SciClone Announces China Government-Mandated ZADA .. 9; Anticipates Minimal Impact on Revenue and Marg
Mon, September 17, 2012
[ Mon, Sep 17th 2012 ] - Market Wire
Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
[ Mon, Sep 17th 2012 ] - Market Wire
Imaging3 Files Chapter 11
[ Mon, Sep 17th 2012 ] - Market Wire
Complete Genomics Inc. Board of Directors Under I .. eaches of Fiduciary Duty by Glancy Binkow & Goldb
[ Mon, Sep 17th 2012 ] - Market Wire
Immunotec Announces Third Quarter 2012 Financial Results
[ Mon, Sep 17th 2012 ] - Market Wire
First Patient Successfully Treated with Innovativ .. t Challenging Atrial Fibrillation Patient Segment
[ Mon, Sep 17th 2012 ] - Market Wire
PAREXEL International Announces $50 Million Accel .. Program And Establishment Of 10b5-1 Trading Plan
[ Mon, Sep 17th 2012 ] - Market Wire
Covidien Expands Device Portfolio for Endovascular Treatment of Peripheral Vascular Disease
[ Mon, Sep 17th 2012 ] - Market Wire
Faruqi & Faruqi, LLP. Launches Investigation Agai .. For Potential Breaches Of Fiduciary Duties By It
[ Mon, Sep 17th 2012 ] - Market Wire
illumigene®; Group A Strep
[ Mon, Sep 17th 2012 ] - Market Wire
Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Complete Genomics, Inc. (GNOM)
[ Mon, Sep 17th 2012 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to BGI-Shenzhen
[ Mon, Sep 17th 2012 ] - Market Wire
AdCare Health Systems Files Resale Registration Statement
[ Mon, Sep 17th 2012 ] - Market Wire
Opexa to Participate at UBS Global Life Sciences Conference
[ Mon, Sep 17th 2012 ] - Market Wire
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Complete Genomics, Inc.
[ Mon, Sep 17th 2012 ] - Market Wire
Securities Lawyers at Goldfarb LLP Seeking More M .. ation for Stockholders of Complete Genomics, Inc.

Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Complete Genomics, Inc.


Published on 2012-09-17 11:47:09 - Market Wire
  Print publication without navigation


DALLAS--([ ])--Securities lawyers at [ Goldfarb LLP ] are investigating alleged violations of shareholder protection laws by officers and directors of Complete Genomics, Inc. (NASDAQ:GNOM) in connection with a buyout for $3.15 per share. Concerned GNOM investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or [ hlindley@goldfarbllp.com ] about their rights and remedies.

"Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed and that the shareholders receive the highest price reasonably available for their GNOM stock."

aThis deal appears to undervalue the company because an analyst has set a target price for Complete Genomics, Inc. stock at $5.00 per share,a said Hamilton Lindley. aOur potential shareholder lawsuit will seek to ensure that all relevant information is disclosed and that the shareholders receive the highest price reasonably available for their GNOM stock.a

Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. GNOM stockholders a" or anyone with knowledge about this acquisition a" should contact lawyer Hamilton Lindley at [ hlindley@goldfarbllp.com ] or 877-583-2855 with questions or concerns.

Contributing Sources